ArticleJournal of pharmacy & bioallied sciences2024
A Comparative Study of Bcl-2 Expression in Oral Leukoplakia with Dysplasia, Verrucous Carcinoma, and Oral Squamous Cell Carcinoma.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To study the immunohistochemical expression of Bcl-2 in oral leukoplakia with dysplasia, verrucous carcinoma and oral squamous cell carcinoma(OSCC). Methodology: A total of 80 formalin-fixed , paraffin- embedded specimens were selected , amongst them 30 cases of different grades of dysplasia- 10 mild, 10 moderate and 10 severe and 30 oral squamous cell carcinoma of various grades- 10 well differentiated, 10 moderately differentiated and 10 poorly differentiated, 10 verrucous carcinoma had been included in the study. 10 normal buccal mucosa were used as control group. Results: The immunohistochemical expression of Bcl-2 in oral leukoplakia with different grades of dysplasia, in verrucous carcinoma and in different grades of oral squamous cell carcinoma with normal mucosa were compared. Moreover, the expression of Bcl-2 was found to increase significantly between dysplasia and different grades of oral squamous cell carcinoma. Conclusion: The expression of Bcl-2 has always guided the researchers towards mapping the progression of dysplasia as well as malignant transformation at the molecular level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.